<dl><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>1</dt><dd id="tr1"><p>{{'LOAD_TRANSACTION'|translate}}</p><ul><li>A file should not be loaded if it is the first REP transaction for this dossier.</li><li>When continuing with a working copy, the format of the file to load should be .hcsc.</li><li>When viewing/updating a final XML file, the format of the file to load should be .xml.</li></ul><p class="fn-rtn"><a href="#tr1_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>1 <span class="wb-inv">referrer</span></a></p></dd><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>2</dt><dd id="tr2"><p>{{::'DOSSIER_TYPE'|translate}}</p><ul><li>Biologic dossier applies to all biologic products and radiopharmaceuticals</li><li>Pharmaceutical dossier applies to all pharmaceutical products, non-prescription products, disinfectants</li></ul><p class="fn-rtn"><a href="#tr2_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>2 <span class="wb-inv">referrer</span></a></p></dd><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>3</dt><dd id="tr3"><P>{{::"COMPANY_ID" |translate}}</P><p>The Company Identifier must be obtained from the final company XML file, issued by Health Canada.</p><p>Company Identification must be 5 digits, add leading zero when required.</p><p class="fn-rtn"><a href="#tr3_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>3 <span class="wb-inv">referrer</span></a></p></dd><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>4</dt><dd id="tr4"><P>{{::"DOSSIER_ID" |translate}}</P><p>The Dossier Identifier can be obtained from Health Canada issued document. The format of a Dossier Identifier is a letter followed by six digits. (e.g. HC6-024-x######).</p><p class="fn-rtn"><a href="#tr4_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>4 <span class="wb-inv">referrer</span></a></p></dd><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>5</dt><dd id="tr5"><p>{{::"PROD_NAME" |translate}}</p><p>The product name is the name assigned by the manufacturer/sponsor to distinguish the drug (product) and under which the drug is to be sold/advertised. It is also the name used to identify the product in all correspondence related to the submission and on the product label(s) and Product Monograph and/or Package Insert, if applicable. If the brand name has not yet been determined, the proper or common name of the drug or the research code may be used.<br><br>The product name input in this field will only be reviewed with the initial transaction of a dossier (sequence 0000). For all subsequence transactions, any changes to the product name should be captured and will be reviewed using the product information template. Product name changes on this template will not be reviewed.</p><p class="fn-rtn"><a href="#tr5_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>5 <span class="wb-inv">referrer</span></a></p></dd><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>6</dt><dd id="tr6"><p>{{'SECTION_IS_NOT_VISIBLE'|translate}} {{::"IS_ADMIN_SUBMISSION" |translate}}</p><div><p>Refer to the <a target="_blank" href="https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/guidance-administrative-processing-human-disinfectant-drugs.html">Guidance Administrative Processing of Submissions and Applications: Human or Disinfectant Drugs</a></p></div><p class="fn-rtn"><a href="#tr6_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>6 <span class="wb-inv">referrer</span></a></p></dd><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>7</dt><dd id="tr7"><p>{{::"CONTROL_NUM" |translate}}</p><ul><li>Enter the 6 digit control number associated with this regulatory activity (if known).</li><li>Enter “000000” for regulatory transactions that Do Not require a control number (e.g. Level III - Post-NOC Changes, UDRA – DIN cancellations, UDRA - Notification Interruption of sale, UDRA - eCTD Dossier Clean-up).</li><li>Enter “000000” for the first transaction of a NEW regulatory activity, where a control number has not yet been assigned.</li><li>Enter the pre-assigned control number for the first transaction of a new regulatory activity that was communicated by Health Canada (e.g. via an Advisement Letter).</li><li>Drug Notification Form(s) (DNF) should be filed under the same control number it has been issued for the product(s) that are now being sold on the market.</li></ul><p class="fn-rtn"><a href="#tr7_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>7 <span class="wb-inv">referrer</span></a></p></dd><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>8</dt><dd id="tr8"><p>{{::'ACTIVITY_LEAD' |translate}}</p><ul><li>Pharmaceutical: Includes all regulatory activities and transactions for prescription pharmaceuticals and pharmaceuticals administered or obtained through a health professional under the Therapeutic Products Directorate (TPD) mandate.</li><li>Biological: Includes all regulatory activities and transactions under the Biologics and Genetic Therapies Directorate (BGTD) mandate (biologics/radiopharmaceutical).</li><li>Post-Market Vigilance: Includes all regulatory activities and transactions under the Marketed Health Products Directorate (MHPD) mandate (prescription and non-prescription pharmaceuticals for human use, biologics, radiopharmaceuticals).</li><li>Consumer Health Products: Includes all regulatory activities and transactions for non-prescription pharmaceuticals under the Natural and Non-Prescription Health Products Directorate (NNHPD) mandate.</li></ul><p class="fn-rtn"><a href="#tr8_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>8 <span class="wb-inv">referrer</span></a></p></dd><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>9</dt><dd id="tr9"><p>{{'SECTION_IS_NOT_VISIBLE'|translate}} {{::'YEAR_CHANGE' |translate}}</p><p>For pharmaceuticals, biologics and radiopharmaceuticals, refer to the:</p><ul><li>Post-Notice of Compliance (NOC) Changes: <a href="https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/post-notice-compliance-changes/quality-document.html" target="_blank">Quality Guidance</a></li><li>Post-Notice of Compliance (NOC) Changes: <a href="https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/post-notice-compliance-changes/safety-efficacy-document.html" target="_blank">Safety and Efficacy</a></li></ul><p>For example, include the year that the change took place, the name of the guidance document and the number or letter of the corresponding change in the appropriate guidance document, when applicable. For example: 2018; Post-NOC Changes: Quality; Changes 15, 18, 23</p><p class="fn-rtn"><a href="#tr9_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>9 <span class="wb-inv">referrer</span></a></p></dd><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>10</dt><dd id="tr10"><p>{{'SECTION_IS_NOT_VISIBLE'|translate}} {{::'BRIEF_DESC_CHANGE' |translate}}</p><p>Reference the applicable appendix sections of the Post-Notice of Compliance (NOC) Changes Guidance Documents and identify the changes.<br>i.e. Quality Document- 3.2.S Drug Substance #1, 2d, 9b, 17,<br>i.e. Quality Document - 3.2.S Drug Substance (Kits/radiopharmaceuticals containing drug substance of chemical origin) - #3, 9, 10c<br>i.e. Safety and Efficacy Document - Supplements - a, d.</p><p class="fn-rtn"><a href="#tr10_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>10 <span class="wb-inv">referrer</span></a></p></dd><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>11</dt><dd id="tr11"><p>{{'SECTION_IS_NOT_VISIBLE'|translate}} {{::'SOLICITED_RQ' |translate}}</p><p>If the name of the requester is unknown, enter the generic email the request was sent from.</p><p class="fn-rtn"><a href="#tr11_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>11 <span class="wb-inv">referrer</span></a></p></dd><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>12</dt><dd id="tr12"><p>{{'SECTION_IS_NOT_VISIBLE'|translate}} {{::'REGULATORY_FEES' |translate}}</p><p>For more information related to fees, refer to the <a target="_blank" href="https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/fees/fees-review-drug-submissions-applications.html">Guidance Document - Fees for the Review of Drug Submissions and Applications</a></p><p class="fn-rtn"><a href="#tr12_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>12 <span class="wb-inv">referrer</span></a></p></dd><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>13</dt><dd id="tr13"><p>{{::'REG_CONTACT_THIS' |translate}}</p><ul><li>Information provided here pertains to <b>the contact specific to the subject regulatory activity,</b> i.e., the person/company to whom Health Canada should direct correspondence about the subject regulatory activity.</li><li>Please note that it is up to the discretion of Health Canada to decide the method of correspondence.</li><li>If you are adding a record to previously submitted final regulatory transaction xml, these fields will be prepopulated with the information of the previous transaction (sequence number).</li><li>Sponsors should update this information if required; otherwise confirm that the information is still valid.</li><li>Enter the name of the company to which the regulatory activity contact belongs. If the contact does not belong to a company, enter the name of the contact.</li></ul><p class="fn-rtn"><a href="#tr13_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>13 <span class="wb-inv">referrer</span></a></p></dd><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>14</dt><dd id="tr14"><p>{{::"COMPANY_NOABBREV" |translate}}</p><p>If the company differs from the sponsor, a letter of authorization signed by the manufacturer/sponsor must be provided in section 1.2.1 of the regulatory transaction.</p><p class="fn-rtn"><a href="#tr14_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>14 <span class="wb-inv">referrer</span></a></p></dd><dt><span class="wb-inv">{{::'INSTRUCTION'|translate}} </span>15</dt><dd id="tr15"><p>{{::'GENERATE_FINAL'|translate}}</p><ul><li>A final regulatory transaction XML file must be included in section 1.2.1 for each of your REP transactions.</li><li>Refer to the REP guidance document for detailed information.</li></ul><p class="fn-rtn"><a href="#tr15_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>15 <span class="wb-inv">referrer</span></a></p></dd></dl>